+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Autophagy in Immune Response: Impact on Cancer Immunotherapy. Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy Volume 1

  • Book

  • May 2020
  • Elsevier Science and Technology
  • ID: 4858543

Autophagy in Immune Response: Impact on Cancer Immunotherapy focuses on the status and future directions of autophagy with respect to different aspects of its interaction with the immune system and immunotherapy. The book takes scientific research in autophagy a step further by presenting reputable information on the topic and offering integrated content with advancements in autophagy, from cell biology and biochemical research, to clinical treatments. This book is a valuable source for cancer researchers, oncologists, graduate students and several members of biomedical field who are interested in learning more on the relationship between autophagy and immunotherapies.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Signaling pathways that control autophagy2. Autophagosome biogenesis3. Autophagy in T and B cell homeostasis: Recycling for sustainable growth4. Autophagy is involved in quality/quantity control of organelles and their homeostasis5. Role of autophagy in immune regulation6. Autophagy in natural and therapy-driven anticancer immunosurveillance7. Autophagy and resistance to cell-mediated cytotoxicity8. Autophagy and metabolism9. Autophagy in connecting immunity and metabolism10. Autophagy in tumor cell migration and invasion, tumor stem cell maintenance and therapy resistance11. Autophagy during Early Virus-Host Cell Interactions12. Diverse roles for autophagy in impeding and promoting tumorigenesis13. The autophagic network and cancer14. Targeting Autophagy in the Tumor Microenvironment15. Autophagy and microbiota16. Regulation of autophagy and mitochondrial dynamics17. Autophagy proteins in cell defenses and role in bacteria-macrophage interaction18. Autophagy, a key player in leukemogenesis and a therapeutic target in hematopoietic malignancies19. Autophagy in Cancer and Cancer Therapy20. Autophagy in the Tumor or in the Host: Which Plays a Greater Supportive Role?21. Autophagy and cancer therapy22. Therapeutic potential of autophagy modulation in the clinic23. Rationale and current approaches for developing autophagy inducers in medicine24. Autophagy and metabolism

Authors

Salem Chouaib Research Director, Gustave Roussy Cancer Center, Villejuif, France. For more than 20 years Dr. Salem Chouaib has focused his research on killer cells and cell death; he first was interested in the differentiation of cytotoxic T lymphocytes, then in the molecular basis of tumor resistance to the cytotoxic action of TNF. During the past ten years, Dr. Chouaib's research was devoted to the influence of tumor microenvironment on stroma reactivity and tumor heterogeneity. His team was the first to establish the link between hypoxic stress and the acquisition of tumor resistance to cell-mediated cytotoxicity; they found in fact that autophagy was a potential pathway linking hypoxia to the acquisition of resistant phenotype including stemness and epithelial to mesenchymal transition. Dr. Chouaib has a wide knowledge of the killing mechanisms and the tumor resistance as well.